These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 14522446

  • 1. Effects of a caffeine-free Cola nitida nuts extract on elastase/alpha-1-proteinase inhibitor balance.
    Daels-Rakotoarison DA, Kouakou G, Gressier B, Dine T, Brunet C, Luyckx M, Bailleul F, Trotin F.
    J Ethnopharmacol; 2003 Nov; 89(1):143-50. PubMed ID: 14522446
    [Abstract] [Full Text] [Related]

  • 2. Effects of Alchornea cordifolia on elastase and superoxide anion produced by human neutrophils.
    Kouakou-Siransy G, Sahpaz S, Nguessan GI, Datté JY, Brou JK, Gressier B, Bailleul F.
    Pharm Biol; 2010 Feb; 48(2):128-33. PubMed ID: 20645828
    [Abstract] [Full Text] [Related]

  • 3. Areca nut extracts reduce the intracellular reactive oxygen species and release of myeloperoxidase by human polymorphonuclear leukocytes.
    Lai YL, Lin JC, Yang SF, Liu TY, Hung SL.
    J Periodontal Res; 2007 Feb; 42(1):69-76. PubMed ID: 17214642
    [Abstract] [Full Text] [Related]

  • 4. Effect of trifluoromethyl ketone-based elastase inhibitors on neutrophil function in vitro.
    Huang YI, Surichamorn W, Cao GL, Meng M, Pou S, Rosen GM, Salcedo TW, Strimpler A, Veale C, Bernstein PR, Bonuccelli CM.
    J Leukoc Biol; 1998 Sep; 64(3):322-30. PubMed ID: 9738658
    [Abstract] [Full Text] [Related]

  • 5. Potentiation of the extracellular release of equine neutrophil elastase and alpha-1-proteinase inhibitor by a combination of two bacterial cell wall components: fMLP and LPS.
    Dagleish MP, Brazil TJ, Scudamore CL.
    Equine Vet J; 2003 Jan; 35(1):35-9. PubMed ID: 12553460
    [Abstract] [Full Text] [Related]

  • 6. An in vitro model for polymorphonuclear-leukocyte-induced injury to an extracellular matrix. Relative contribution of oxidants and elastase to fibronectin release from amnionic membranes.
    Sibille Y, Lwebuga-Mukasa JS, Polomski L, Merrill WW, Ingbar DH, Gee JB.
    Am Rev Respir Dis; 1986 Jul; 134(1):134-40. PubMed ID: 3014933
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro.
    Carp H, Janoff A.
    J Clin Invest; 1980 Nov; 66(5):987-95. PubMed ID: 6253528
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inactivation of alpha-1-proteinase inhibitor by neutrophil metalloproteinases. Crucial role of the myeloperoxidase system and effects of the anti-inflammatory drug nimesulide.
    Ottonello L, Dapino P, Dallegri F.
    Respiration; 1993 Nov; 60(1):32-7. PubMed ID: 8385794
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory activity of thymol: inhibitory effect on the release of human neutrophil elastase.
    Braga PC, Dal Sasso M, Culici M, Bianchi T, Bordoni L, Marabini L.
    Pharmacology; 2006 Nov; 77(3):130-6. PubMed ID: 16763380
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Formation of polymorphonuclear leukocyte elastase: alpha 1 proteinase inhibitor complex and A alpha (1-21) fibrinopeptide in human blood stimulated with the calcium ionophore A23187. A model to characterize inhibitors of polymorphonuclear leukocyte elastase.
    Pacholok SG, Davies P, Dorn C, Finke P, Hanlon WA, Mumford RA, Humes JL.
    Biochem Pharmacol; 1995 May 17; 49(10):1513-20. PubMed ID: 7763294
    [Abstract] [Full Text] [Related]

  • 15. Inactivation of alpha-1-proteinase inhibitor in serum by stimulated human polymorphonuclear leucocytes. Evidence for a myeloperoxidase-dependent mechanism.
    Shock A, Baum H.
    Cell Biochem Funct; 1988 Jan 17; 6(1):13-23. PubMed ID: 2832092
    [Abstract] [Full Text] [Related]

  • 16. Protease-modulation of neutrophil superoxide response.
    Kusner DJ, King CH.
    J Immunol; 1989 Sep 01; 143(5):1696-702. PubMed ID: 2547873
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neutrophils obtained from obliterative atherosclerotic patients exhibit enhanced resting respiratory burst and increased degranulation in response to various stimuli.
    Mohàcsi A, Kozlovszky B, Kiss I, Seres I, Fülöp T.
    Biochim Biophys Acta; 1996 Aug 23; 1316(3):210-6. PubMed ID: 8781540
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
    Fletcher MP, Stahl GL, Longhurst JC.
    J Leukoc Biol; 1990 Apr 23; 47(4):355-65. PubMed ID: 2108228
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.